Incidence of pancreatic injury and pancreatitis in patients treated with immune checkpoint inhibitors.

Yasuki HoriItaru NaitohAya Naiki-ItoTatsuya KawaiMichihiro YoshidaAkihisa KatoKenta KachiHidenori SahashiAkihisa AdachiTadashi ToyoharaYusuke KitoTatsuhito YamamotoSatoru TakahashiHiromi Kataoka

Published in: Clinical and translational gastroenterology (2023)

Simultaneous immunotherapy and dual immunotherapy are risk factors for ICI-PI. Although most patients diagnosed with ICI-PI and ICI-associated pancreatitis were asymptomatic and had a low mortality likelihood, long-term outcomes, including endocrine and exocrine function should be carefully monitored.

Keyphrases

end stage renal disease
ejection fraction
risk factors
newly diagnosed
chronic kidney disease
peritoneal dialysis
cardiovascular events
cardiovascular disease
patient reported